尤洛卡 reported revenue of ¥0.19B for the period ended 2026-06-30, -21.3% year on year. Net income was ¥0.03B, a 16.0% net margin on a 50.9% gross margin. Free cash flow for the period was ¥0.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | -21.3% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | -13.9% |
| Gross margin | 50.9% | Net margin 16.0% |
| Revenue Q/Q | +89.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 49.1% |
| R&D | ¥0.02B | 9.8% |
| SG&A | ¥0.05B | 25.1% |
| Tax & other | ¥0.00B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | ¥2.53B |
| Total liabilities | ¥0.21B |
| Shareholders' equity | ¥2.31B |
| Equity / assets | 91.6% |
| Operating cash flow | ¥0.05B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.05B |
| Cash conversion (OCF / net income) | 120% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
双林股份 ・ 振芯科技 ・ 乾照光电 ・ 达刚控股 ・ 龙源技术 ・ 西部牧业 ・ 建新股份 ・ 新开源 ・ 华仁药业 ・ 向日葵 ・ 万讯自控 ・ 顺网科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies